Colitis with wall thickening and edematous changes during oral administration of the powdered form of Qing-dai in patients with ulcerative colitis: a report of two cases
- PMID: 29549501
- DOI: 10.1007/s12328-018-0851-7
Colitis with wall thickening and edematous changes during oral administration of the powdered form of Qing-dai in patients with ulcerative colitis: a report of two cases
Abstract
Orally administered Qing-dai, called indigo naturalis in Latin, is reportedly useful for the treatment of ulcerative colitis. We herein describe two patients with ulcerative colitis who developed colitis with wall thickening and edematous changes during oral administration of the powdered form of Qing-dai. In Case 1, a 35-year-old man developed colitis similar to ischemic colitis with bloody stool that recurred each time he ingested Qing-dai. He had no signs of recurrence upon withdrawal of Qing-dai. In Case 2, a 43-year-old woman underwent ileocecal resection for treatment of an intussusception 2 months after beginning oral administration of Qing-dai. Edema and congestion but no ulceration were present in the mucosa of the resected specimen. Both patients exhibited abdominal pain with bloody diarrhea, and abdominal computed tomography showed marked wall edema affecting an extensive portion of the large bowel.
Keywords: Adverse effect; Colitis; Indigo naturalis; Intussusception; Qing-dai.
Similar articles
-
Ischemic colitis induced by indigo naturalis in a patient with ulcerative colitis: a case report.BMC Gastroenterol. 2020 May 15;20(1):154. doi: 10.1186/s12876-020-01301-3. BMC Gastroenterol. 2020. PMID: 32414334 Free PMC article.
-
Clinical Efficacy and Safety of Oral Qing-Dai in Patients with Ulcerative Colitis: A Single-Center Open-Label Prospective Study.Digestion. 2016;93(3):193-201. doi: 10.1159/000444217. Epub 2016 Mar 10. Digestion. 2016. PMID: 26959688 Clinical Trial.
-
Dramatically Improved Severe Pulmonary Arterial Hypertension Caused by Qing-Dai (Chinese Herbal Drug) for Ulcerative Colitis.Int Heart J. 2023;64(2):316-320. doi: 10.1536/ihj.22-563. Int Heart J. 2023. PMID: 37005323
-
Indigo naturalis (Qing dai) for inflammatory bowel disease: A systematic review and meta-analysis.Clin Res Hepatol Gastroenterol. 2024 Jan;48(1):102250. doi: 10.1016/j.clinre.2023.102250. Epub 2023 Nov 23. Clin Res Hepatol Gastroenterol. 2024. PMID: 38006941
-
Qing-Dai for pediatric ulcerative colitis multicenter survey and systematic review.Pediatr Int. 2022 Jan;64(1):e15113. doi: 10.1111/ped.15113. Pediatr Int. 2022. PMID: 35831249
Cited by
-
A Comprehensive Review of the Chemistry, Pharmacokinetics, Pharmacology, Clinical Applications, Adverse Events, and Quality Control of Indigo Naturalis.Front Pharmacol. 2021 May 31;12:664022. doi: 10.3389/fphar.2021.664022. eCollection 2021. Front Pharmacol. 2021. PMID: 34135755 Free PMC article. Review.
-
Adverse events in patients with ulcerative colitis treated with indigo naturalis: a Japanese nationwide survey.J Gastroenterol. 2019 Oct;54(10):891-896. doi: 10.1007/s00535-019-01591-9. Epub 2019 May 17. J Gastroenterol. 2019. PMID: 31102012
-
Herbal Medicines for the Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis.Nutrients. 2024 Mar 23;16(7):934. doi: 10.3390/nu16070934. Nutrients. 2024. PMID: 38612967 Free PMC article.
-
Indigo naturalis‑associated ischemic injury of colorectal mucosa: A case series study.Exp Ther Med. 2025 Feb 7;29(4):68. doi: 10.3892/etm.2025.12818. eCollection 2025 Apr. Exp Ther Med. 2025. PMID: 39991716 Free PMC article.
-
Ischemic colitis induced by indigo naturalis in a patient with ulcerative colitis: a case report.BMC Gastroenterol. 2020 May 15;20(1):154. doi: 10.1186/s12876-020-01301-3. BMC Gastroenterol. 2020. PMID: 32414334 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical